PT Prodia Widyahusada Tbk

Jakarta Stock Exchange PRDA.JK

PT Prodia Widyahusada Tbk Operating Income for the year ending December 31, 2023: USD 20.05 M

PT Prodia Widyahusada Tbk Operating Income is USD 20.05 M for the year ending December 31, 2023, a -29.91% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

PT Prodia Widyahusada Tbk Operating Income for the year ending December 31, 2022 was USD 28.61 M, a -45.98% change year over year.
PT Prodia Widyahusada Tbk Operating Income for the year ending December 31, 2021 was USD 52.96 M, a 150.73% change year over year.
PT Prodia Widyahusada Tbk Operating Income for the year ending December 31, 2020 was USD 21.12 M, a 35.79% change year over year.
PT Prodia Widyahusada Tbk Operating Income for the year ending December 31, 2019 was USD 15.56 M, a 25.30% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Jakarta Stock Exchange: PRDA.JK

PT Prodia Widyahusada Tbk

CEO	Ms. Dewi Muliaty
IPO Date	Dec. 9, 2016
Location	Indonesia
Headquarters	Prodia Tower
Employees	2,974
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals

Description

PT Prodia Widyahusada Tbk provides private clinical laboratory services. The company offers laboratory, panel test, and other diagnostics support services. As of December 31, 2021, it operated 259 outlets comprising 10 Prodia Health Care and specialty clinic outlets, 142 clinical lab and medical labs, 98 point of care outlets, and 9 hospital collaboration labs in 34 provinces throughout Indonesia. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk is a subsidiary of PT Prodia Utama.

Key trends

Past 5 years